Studies of central nervous system disorders with single photon emission computed tomography and positron emission tomography: Evolution over the past 2 decades

Kuhl, 1963, Mage separation of radioisotope scanning, Radiology, 80, 653, 10.1148/80.4.653 Kuhl, 1976, The MARK IV system for radionuclide computed tomography of the brain, Radiology, 121, 405, 10.1148/121.2.405 Hounsfield, 1973, Computerized transverse axial scanning (tomography). I. Description of system, Br J Radiol, 46, 1023, 10.1259/0007-1285-46-552-1016 Ambrose, 1973, Computerized transverse axial scanning (tomography): II. Clinical application, Br J Radiol, 46, 1023, 10.1259/0007-1285-46-552-1023 Kuhl, 1980, Local cerebral blood volume in head-injured patients: Determination by emission computed tomography of Tc-99m labeled red cells, J Neurosurg, 52, 309, 10.3171/jns.1980.52.3.0309 Sokoloff, 1977, The (14C) deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure and normal values in the conscious and anesthetized albino rat, J Neurochem, 28, 897, 10.1111/j.1471-4159.1977.tb10649.x Ido, 1978, Labeled 2-deoxyglucose analogs. 18F-labeled 2-deoxyglucose-2-fluoro-D-glucose, 2-deoxy-2-fluoro-D-manose and 14C-2-deoxy-2-fluoro-D-glucose, J Label Comp Radiopharm, 14, 175, 10.1002/jlcr.2580140204 Ter-Pogossian, 1975, A positron emission transaxial tomograph for nuclear medicine imaging (PET), Radiology, 114, 89, 10.1148/114.1.89 Phelps, 1976, Design considerations for a positron emission transaxial tomograph (PETT-III), IEEE Trans Nucl Sci NS, 23, 516, 10.1109/TNS.1976.4328298 Winchell, 1980, N-isopropyl (iodine-123) p-iodoamphetamine: Single pass brain uptake and washout: Binding to brain synaptosomes and localisation in dog and monkey brain, J Nucl Med, 21, 947 Kung, 1983, A new brain perfusion imaging agent: N,N,N′ trimethyl-N-(2 hydroxy-3-methyl-5-iodobenzyl)-1,3 propanediamine (HIPDM), J Nucl Med, 24, 66 Kuhl, 1982, Quantifying local cerebral blood flow by N-isopropyl-p-123 I iodoamphetamine (IMP) tomography, J Nucl Med, 23, 196 Royal, 1985, Clinical brain imaging with isoprapyl-iodoamphetamine and SPECT, Semin Nucl Med, 15, 357, 10.1016/S0001-2998(85)80014-3 Ell, 1987, Functional imaging of the brain, Semin Nucl Med, 17, 214, 10.1016/S0001-2998(87)80035-1 Walovitch, 1988, Brain retention of Tc99m-ECD is related to in vivo metabolism, J Nucl Med, 29, 5 Sokoloff, 1981, Relationship among local functional activity, energy metabolism and blood flow in central nervous system, Fed Proc, 40, 2311 Choki, 1981, Correlation between blood flow and glucose metabolism in the focal cerebral ischemia in the cat: An application of double label autoradiographic method, J Cereb Blood Flow Metab, 3, S399 Wagner, 1983, Imaging dopamine receptors in the human brain by positron tomography, Science, 221, 1264, 10.1126/science.6604315 Kebabian, 1979, Multiple receptors for dopamine, Nature, 277, 93, 10.1038/277093a0 Stoof, 1984, Two dopamine receptors: Biochemistry, physiology, and pharmacology, Life Sci, 35, 2281, 10.1016/0024-3205(84)90519-8 Seeman, 1982, Nomenclature of central and peripheral dopaminergic sites and receptors, Biochem Pharmacol, 31, 2563, 10.1016/0006-2952(82)90700-6 Breese, 1986 Raisman, 1985, Binding of [3H]SCH 23390 to D-1 receptors in the putamine of control and parkinsonian subjects, Eur J Pharmacol, 113, 467, 10.1016/0014-2999(85)90101-3 Creese, 1987 Saller, 1985, Dopamine receptor subtypes: In vivo biochemical evidence for functional interaction, Eur J Pharmacol, 109, 297, 10.1016/0014-2999(85)90435-2 Walters, 1987, D-1 dopamine receptor activation required for postsynaptic expression of D-2 agonist effects, Science, 236, 719, 10.1126/science.2953072 Robertson, 1987, D1 and D2 dopamine agonist synergism: Separate sites of action, Trends Pharmacol Sci, 8, 295, 10.1016/0165-6147(87)90121-0 Waddington, 1989, Sight and insight: Brain dopamine receptor occupancy by neuroleptics visualised in living schizophrenic patients by PET, Br J Psychiatry, 154, 433, 10.1192/bjp.154.4.433 Seeman, 1989, Link between D1 and D2 dopamine receptors in reduced in schizophrenia and Huntington diseased brain, Proc Natl Acad Sci USA, 86, 10156, 10.1073/pnas.86.24.10156 Wong, 1984, Effects of age on dopamine and serotonin receptors measured by positron tomography in the human brain, Science, 226, 1393, 10.1126/science.6334363 Rinne, 1990, PET demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease, Mov Disord, 5, 55, 10.1002/mds.870050114 Raisman, 1985, Binding of [3H]SCH 23390 to D-1 receptors in the putamen of control and parkinsonian subjects, Eur J Pharmacol, 113, 467, 10.1016/0014-2999(85)90101-3 Seeman, 1987, Dopamine receptors and the dopamine hypothesis of schizophrenia, Synapse, 1, 133, 10.1002/syn.890010203 Carlsson, 1988, The current status of the dopamine hypothesis of schizophrenia, Neuropsychopharmacology, 1, 179, 10.1016/0893-133X(88)90012-7 Duara, 1983, Cerebral glucose utilization as measured with positron emission tomography in 21 resting healthy men between the ages of 21 and 83 years, Brain, 106, 761, 10.1093/brain/106.3.761 deLeon, 1985, PET scanning demonstrates that aging in man is accompanied by loss of integration of regional brain activity without concurrent reduction in absolute regional cerebral metabolic rates for glucose, J Cereb Blood Flow Metab, 5, S119 Alavi, 1989, The aging brain, J Neuropsychiatry, 1, S51 Dastur, 1985, Cerebral blood flow and metabolism in normal human aging, pathological aging, and senile dementia, J Cereb Blood Flow Metab, 5, 1, 10.1038/jcbfm.1985.1 Kuhl, 1987, Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F]fluorodeoxyglucose method, J Cereb Blood Flow Metab, 7, S411 Chawluk, 1987, Changes in local cerebral glucose metabolism with normal aging, the effects of cardiovascular and systemic health factors, J Cereb Blood Flow Metab, 7, S411 deLeon, 1987, Positron emission tomography studies of normal aging, a replication of PET III and 18-FDG using PET VI and II-CDG, Neurobiol Aging, 8, 319, 10.1016/0197-4580(87)90070-4 Chawluk, 1985, Altered patterns, J Cereb Blood Flow Metab, 5, S121 Yoshii, 1988, Sensitivity of cerebral glucose metabolism to age, gender, brain volume, brain atrophy, and cerebrovascular risk factors, J Cereb Blood Flow Metab, 8, 654, 10.1038/jcbfm.1988.112 Alavi, 1986, Positron emission tomography imaging of regional cerebral glucose metabolism, Semin Nucl Med, 16, 2, 10.1016/S0001-2998(86)80002-2 Duara, 1986, Positron emission tomography in Alzheimer's disease, Neurology, 36, 879, 10.1212/WNL.36.7.879 Alavi, 1985, Determination of patterns of regional cerebral glucose metabolism in normal aging and dementia, J Nucl Med, 26, 69 Alavi, 1989, Anatomical and functional changes of the brain in normal aging and dementia as demonstrated by MRI, CT, and PET, Nucl Med Ann, 49 Alavi, 1989, Correlation of visual symptoms with regional cerebral glucose metabolic images in Alzheimer's disease, J Nucl Med, 30, 772 Frackowiak, 1981, Regional cerebral oxygen supply and utilization in dementia: A clinical and physiological study with oxygen-15 and positron tomography, Brain, 104, 753, 10.1093/brain/104.4.753 Frackowiak, 1981, A prospective study of regional cerebral blood flow and oxygen utilization in dementia using positron emission tomography and oxygen-15, J Cereb Blood Flow Metab, 1, S453 Jamieson, 1987, The effect of disease severity on local cerebral glucose metabolism in Alzheimer's disease, J Cereb Blood Flow Metab, 7, 410 Benson, 1983, The fluorodeoxyglucose 123F scan in Alzheimer's disease and multi-infarct dementia, Arch Neurol, 40, 711, 10.1001/archneur.1983.04050110029003 Kamo, 1987, Positron emission tomography and histopathology in Pick's disease, Neurology, 37, 439, 10.1212/WNL.37.3.439 Derouesne, 1985, Variability of cerebral blood flow defects in Alzheimer's disease on 123-iodo-isopropyl-amphetamine and single-photon emission tomography, Lancet, 1, 282 Hellman, 1989, Alzheimer disease: Quantitative analysis of I-123-iodoamphetamine SPECT brain imaging, Radiology, 172, 183, 10.1148/radiology.172.1.2787034 Sharp, 1986, Application of iodine-123-labeled isopropylamphetamine imaging to the study of dementia, J Nucl Med, 27, 769 Jagust, 1987, The diagnosis of dementia with single photon emission computed tomography, Arch Neurol, 44, 258, 10.1001/archneur.1987.00520150014011 Johnson, 1987, Cerebral perfusion imaging in Alzheimer's disease: Use of single photon emission computed tomography and iofetamine hydrochloride I-123, Arch Neurol, 44, 165, 10.1001/archneur.1987.00520140035014 Bonte, 1989, The effect of acetazolamide on regional cerebral blood flow in patients with Alzheimer's disease or stroke as measured by singlephoton emission computed tomography, Invest Radiol, 24, 99, 10.1097/00004424-198902000-00002 Komatani, 1988, Assessment of demented patients by dynamic SPECT of inhaled xenon-133, J Nucl Med, 29, 1621 Chawluk, 1987, Positron emission tomography in aging and dementia: Effect of cerebral atrophy, J Nucl Med, 28, 431 O'Tuama, 1989, Methionine transport in brain tumors, J Neuropsychiatry, 1, S37 Hiesiger, 1986, Serial PET studies of human cerebral malignancy with [1-11C] putrescine (11C-PUT) and [1-11C]2-deoxy-D-glucose (11C-2DG), J Nucl Med, 27, 889 Di Chiro, 1986, Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool, Invest Radiol, 22, 360, 10.1097/00004424-198705000-00002 Di Chiro, 1982, Glucose utilization of cerebral gliomas measured by 18F fluorodeoxyglucose and positron emission tomography, Neurology, 32, 1323, 10.1212/WNL.32.12.1323 Patronas, 1983, Glycolytic rate (PET) and contrast enhancement (CT) in human cerebral gliomas, Am J Neuroradiol, 533 Alavi, 1985, Metabolic brain imaging correlated with clinical features and brain tumors, J Nucl Med, 18, 64 Alavi, 1988, Positron emission tomography in patients with glioma. A predictor of prognosis, Cancer, 62, 1074, 10.1002/1097-0142(19880915)62:6<1074::AID-CNCR2820620609>3.0.CO;2-H Kushner, 1987, Cerebellar glucose consumption in normal and pathologic states using fluorine-FDG and PET, J Nucl Med, 28, 1667 Baron, 1981, Crossed cerebellar diaschisis: A remote functional depression secondary to supratentorial infarction in man, J Cereb Blood Flow Metab, 1, S500 Doyle, 1987, Differentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography, J Comput Axial Tomogr, 11, 563, 10.1097/00004728-198707000-00001 Patronas, 1982, Work in progress: (18F) fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain, Radiology, 144, 885, 10.1148/radiology.144.4.6981123 Di Chiro, 1988, Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies, AJR, 150, 189, 10.2214/ajr.150.1.189 Valk, 1988, Positron emission tomography of malignant cerebral tumors after interstitial brachytherapy: Demonstration of metabolic activity and correlation with clinical outcome, J Neurosurg, 69, 830, 10.3171/jns.1988.69.6.0830 Ogawa, 1988, Changes of cerebral blood flow and oxygen and glucose metabolism following radiochemotherapy of gliomas: A PET study, J Comput Assist Tomogr, 12, 290, 10.1097/00004728-198803000-00019 Langen, 1987, Tomographic studies of rCBF with 99mTc-HM-PAO SPECT in comparison with PET in patients with primary brain tumors, Neurosurg Rev, 10, 23, 10.1007/BF01780589 Schad, 1987, Three dimensional correlation of CT, MR, and PET studies in radiotherapy treatment planning of brain tumors, J Comput Axial Tomogr, 11, 948, 10.1097/00004728-198711000-00005 Langfitt, 1986, Computerized tomography, magnetic resonance imaging, and positron emission tomography in the study of brain trauma. Preliminary observations, J Neurosurg, 64, 760, 10.3171/jns.1986.64.5.0760 Alavi, 1987, Positron emission tomography in the evaluation of head injury, J Cereb Blood Flow Metab, 7, 646 George, 1989, Metabolic (PET) correlates of anatomic lesions (CT/MRI) produced by head trauma, J Nucl Med, 30, 802 Alavi, 1989, Functional and anatomic studies of head injury, J Neuropsychiatry, 1, S45 Alavi, 1990, Unusual patterns of cerebellar hypometabolism in head trauma (HT), J Nucl Med, 31, 741 Souder, 1990, Correlation of FDG-PET and neuropsychological findings in head injured patients preliminary data, J Nucl Med, 31, 876 Abdel-Dayem, 1987, Changes in cerebral perfusion after acute head injury: Comparison of CT with Tc-99m HM-PAO SPECT, Radiology, 165, 221, 10.1148/radiology.165.1.3498184 Bruce, 1979, The pathophysiology, treatment, and outcome following severe head injury in children, Childs Brain, 5, 174 Langfitt, 1966, The etiology of acute brain swelling following experimental head injury, J Neurosurg, 24, 47, 10.3171/jns.1966.24.1.0047 Langfitt, 1965, Cerebral vasomotor paralysis produced by intracranial hypertension, Neurology, 15, 622, 10.1212/WNL.15.7.622 Obrist, 1975, Regional cerebral blood flow estimated by 133xenon inhalation, Stroke, 6, 245, 10.1161/01.STR.6.3.245 Risberg, 1969, Regional cerebral blood volume during acute transient rises of the intracranial pressure (plateau waves), J Neurosurg, 31, 303, 10.3171/jns.1969.31.3.0303 Shapiro, 1966, Compression of cerebral vessels by intracranial hypertension, Acta Neurochir, 15, 223, 10.1007/BF01406784 Zimmerman, 1978, Computed tomography of pediatric head trauma: Acute general cerebral swelling, Radiology, 126, 403, 10.1148/126.2.403 Overgaard, 1976, Cerebral circulation after head injury. Part 1: Cerebral blood flow and its regulation after closed head injury with emphasis on clinical correlations, J Neurosurg, 41, 531, 10.3171/jns.1974.41.5.0531 Kushner, 1987, Metabolic and clinical correlates of acute ischemic infarction, Neurology, 37, 1103, 10.1212/WNL.37.7.1103 Kuhl, 1980, Effect of stroke on local cerebral metabolism and perfusion: Mapping by emission computed tomography of 18FDG and 13NH3, Ann Neurol, 8, 47, 10.1002/ana.410080108 Lassen, 1966, The luxury perfusion syndrome and its possible relation to acute metabolic acidosis localized within the brain, Lancet, 2, 1113, 10.1016/S0140-6736(66)92199-4 Baron, 1981, Reversal of focal “misery-perfusion syndrome” by extracranial bypass in hemodynamic cerebral ischemia, Stroke, 12, 454, 10.1161/01.STR.12.4.454 Ackerman, 1981, Positron imaging in ischemic stroke disease using compounds labeled with oxygen 15, Arch Neurol, 38, 537, 10.1001/archneur.1981.00510090031002 Frackowiak, 1983, Positron tomography in ischemic cerebrovascular disease, Neurol Clin, 1, 183, 10.1016/S0733-8619(18)31178-2 Itoh, 1988, Positron CT imaging of an impending stroke, Neuroradiol, 30, 276, 10.1007/BF00341844 Pappata, 1987, Remote metabolic effects of cerebrovascular lesions: magnetic resonance and positron tomography imaging, Neuroradiology, 29, 1, 10.1007/BF00341027 Killen, 1989, An assessment of the role of I-123-N-isopropyl-p-iodoamphetamine with single-photon emission computed tomography in the diagnosis of stroke and Alzheimer's disease, Nucl Med Commun, 10, 217, 10.1097/00006231-198904000-00004 Buell, 1984, Dynamic SPECT with 133Xe: Regional cerebral blood flow in patients with unilateral cerebrovascular disease. Concise Communication, J Nucl Med, 25, 441 Hill, 1984, Assessment of regional cerebral blood flow (rCBF) in stroke using SPECT and N-isopropyl-(I-123)-p-iodoamphetamine (IMP), Stroke, 15, 40, 10.1161/01.STR.15.1.40 Rango, 1989, Cortical pathophysiology and clinical neurologic abnormalities in acute cerebral ischemia: A serial study with single photon emission computed tomography, Arch Neurol, 46, 1318, 10.1001/archneur.1989.00520480060021 Maurer, 1990, SPECT quantification of cerebral ischemia before and after carotid endarterectomy, J Nucl Med, 31, 1412 Creutzig, 1986, Cerebral dynamics of N-isopropyl-I-123-p-iodoamphetamine, J Nucl Med, 27, 178 Defer, 1987, Early and delayed SPECT using N-isopropyl p-iodoamphetamine iodine 123 in cerebral ischemia: A prognostic index for clinical recovery, Arch Neurol, 44, 715, 10.1001/archneur.1987.00520190027012 Moretti, 1987, Early and delayed IMP I-123 SPECT as a prognostic index for clinical recovery in cerebral ischemia, J Nucl Med, 28, 623 Maurer, 1988, Significance of patterns of I-123 iodoamphetamine redistribution for predicting successful revascularization following carotid endarterectomy, J Nucl Med, 29, 844 Higa, 1986, SPECT with N-isopropyl-p-iodoamphetamine in occlusive cerebrovascular diseases, Clin Nucl Med, 12, 855, 10.1097/00003072-198612000-00013 Mountz, 1990, Prognostication of recovery following stroke using the comparison of CT and technetium-99m HM-PAO SPECT, J Nucl Med, 31, 61 Norrving, 1985, rCBF in patients with carotid occlusion: Resting and hypercapnic flow related to collateral pattern, Stroke, 13, 155, 10.1161/01.STR.13.2.155 Bullock, 1984, Cerebral blood flow measurement as an indicator of the haemodynamic severity of carotid artery disease in man, S Afr Med J, 65, 429 Sullivan, 1987, The rCBF response to Diamox in normal subjects and cerebrovascular disease patients, J Neurosurg, 67, 525, 10.3171/jns.1987.67.4.0525 Baron, 1989, Use of PET methods for measurement of cerebral energy metabolism and hemodynamics in cerebrovascular disease, J Cereb Blood Flow Metab, 9, 723, 10.1038/jcbfm.1989.105 Gibbs, 1984, Evaluation of cerebral perfusion reserve in patients with carotid-artery occlusion, Lancet, 1, 310, 10.1016/S0140-6736(84)90361-1 Knapp, 1986, Imaging of cerebral blood flow-to-volume distribution using SPECT, J Nucl Med, 27, 465 Buell, 1988, Combined SPECT imaging of regional cerebral blood flow (99mTc-hexamethyl-propyleneamine oxime, HMPAO) and blood volume (99mTc-RBC) to assess regional cerebral perfusion reserve in patients with cerebrovascular disease, Nuklearmedizin, 27, 51, 10.1055/s-0038-1629503 Bushnell, 1987, Demonstration of focal hyperemia in acute cerebral infarction with iodine-123 iodoamphetamine, J Nucl Med, 28, 1920 Buell, 1987, SPECT with 99Tcm-HMPAO and 99Tcm-pertechnetate to assess regional cerebral blood flow (rCBF) and blood volume (rCBV). Preliminary results in cerebrovascular disease and interictal epilepsy, Nucl Med Commun, 8, 519 Meneghetti, 1984, Crossed cerebellar diaschisis in ischemic stroke: A study of regional cerebral blood flow by 133 Xe inhalation and single-photon emission computerized tomography, J Cereb Blood Flow Metab, 4, 235, 10.1038/jcbfm.1984.32 Pantano, 1987, Crossed cerebellar diaschisis in patients with cerebral ischemia assessed by SPECT and I-123-HIPDM, Eur Neurol, 27, 142, 10.1159/000116147 Perani, 1987, Cerebral hemispheric and contralateral cerebellar hypoperfusion during a transient ischemic attack, J Cereb Blood Flow Metab, 7, 507, 10.1038/jcbfm.1987.95 Perani, 1988, Remote effects of subcortical cerebrovascular lesions: A SPECT cerebral perfusion study, J Cereb Blood Flow Metab, 8, 560, 10.1038/jcbfm.1988.97 Johansson, 1988, Cerebral infarctions studied by I-123-iodoamphetamine, Eur Neurol, 28, 18, 10.1159/000116221 Perani, 1988, Remote effects of subcortical cerebrovascular lesions: A SPECT cerebral perfusion study, J Cereb Blood Flow Metab, 8, 560, 10.1038/jcbfm.1988.97 Soucy, 1990, Evaluation of vasospasm secondary to subarachnoid hemorrhage with technetium-99m-hexamethyl-propyleneamine oxime (HM-PAO) tomoscintigraphy, J Nucl Med, 31, 972 Smith, 1988, Technetium 99m HMPAO scanning in patients with subarachnoid haemorrhage: A preliminary study, Br J Radiol, 61, 26, 10.1259/0007-1285-61-721-26 1990, 264, 729 Spencer, 1986, Surgical options for uncontrolled epilepsy, Neurol Clin, 4, 669, 10.1016/S0733-8619(18)30969-1 Engel, 1982, Patterns of ictal and interictal local cerebral metabolic rate studied in man with positron computed tomography, 145 Engel, 1982, Pathologic findings underlying focal temporal lobe hypometabolism in partial epilepsy, Ann Neurol, 12, 518, 10.1002/ana.410120604 Theodore, 1984, The role of positron emission tomography in the evaluation of seizure disorders, Ann Neurol, 15, S176, 10.1002/ana.410150734 Engel, 1983, Local cerebral metabolism during partial seizures, Neurology, 33, 400, 10.1212/WNL.33.4.400 Rowe, 1989, Localization of epileptic foci with postical single photon emission computed tomography, Ann Neurol, 26, 660, 10.1002/ana.410260512 LaManna, 1989, Initial experience with SPECT imaging of the brain using I-123 p-iodoamphetamine in focal epilepsy, Clin Nucl Med, 14, 428, 10.1097/00003072-198906000-00006 Podreka, 1987, Initial experience with technetium-99m HM-PAO brain SPECT, J Nucl Med, 28, 1657 Ryding, 1988, SPECT measurements with 99m Tc-HM-PAO in focal epilepsy, J Cereb Blood Flow Metab, 8, S95, 10.1038/jcbfm.1988.38 Stefan, 1987, Functional and morphologic abnormalities in temporal lobe epilepsy: A comparison of interictal and ictal EEG, CT, MRI, SPECT and PET, J Neurol, 234, 377, 10.1007/BF00314081 Lee, 1988, HIPDM-SPECT in patients with medically intractable complex partial seizures: Ictal study, Arch Neurol, 45, 397, 10.1001/archneur.1988.00520280043014 Bonte, 1983, Single-photon tomographic determination of regional cerebral blood flow in epilepsy, AJNR, 4, 544 Homan, 1989, Cognitive function and regional cerebral blood flow in partial seizures, Arch Neurol, 46, 964, 10.1001/archneur.1989.00520450034016 Lang, 1988, Single photon emission computed tomography during and between seizures, J Neurol, 235, 277, 10.1007/BF00314174 Lee, 1986, Single photon emission computed tomography (SPECT) brain imaging using, N,N,N-trimethyl-N-(2 hydroxy-3-methyl-5-I-123-iodobenzyl)-1,3-propanediamine 2 HCl (HIPDM): intractable complex partial seizures, Neurology, 36, 1471, 10.1212/WNL.36.11.1471 Lee, 1987, HIPDM single photon emission computed tomography brain imaging in partial onset secondarily generalized tonic-clonic seizures, Epilepsia, 28, 305, 10.1111/j.1528-1157.1987.tb04223.x Biersack, 1986, A comparative study of brain uptake and early kinetics of 99mTc-dl HM-PAO and other PnAO derivatives in baboons, Nucl Med, 25, 134 Biersack, 1985, 99mTc-labeled hexamethypropyl-eneamine oxime photon emission scans in epilepsy, Lancet, 2, 1436, 10.1016/S0140-6736(85)92612-1 Biersack, 1988, Brain SPECT in epilepsy, Adv Function Neuroimag, 1, 4 Savic, 1988, In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci, Lancet, 2, 863, 10.1016/S0140-6736(88)92468-3 Frost, 1988, Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy, Ann Neurol, 23, 231, 10.1002/ana.410230304 Vonsattel, 1985, Neurophathological classification of Huntington's disease, J Neuropathol Exp Neurol, 44, 559, 10.1097/00005072-198511000-00003 Koh, 1985, Neurons containing NADPH-diaphorase are selectively resistant to quinolate toxicity, Science, 230, 561 Brooks, 1989, PET and movement disorders, J Neurol Neurosurg Psychiatry, 52, S68, 10.1136/jnnp.52.Suppl.68 Kuhl, 1982, Cerebral metabolism and atrophy in Huntington's disease determined by 18-FDG and computed tomographic scan, Ann Neurol, 12, 425, 10.1002/ana.410120504 Hayden, 1986, Positron emission tomography in the early diagnosis of Huntington's disease, Neurology, 36, 888, 10.1212/WNL.36.7.888 Young, 1986, PET scan investigations of Huntington's disease: Cerebral metabolic correlates of neurological features and functional decline, Ann Neurol, 20, 296, 10.1002/ana.410200305 Berent, 1988, Positron emission tomographic scan investigations of Huntington's disease: Cerebral metabolic correlates of cognitive function, Ann Neurol, 23, 541, 10.1002/ana.410230603 Smith, 1988, The use of technetium-99m-HM-PAO in the assessment of patients with dementia and other neuropsychiatric conditions, J Cereb Blood Flow Metab, 8, 115, 10.1038/jcbfm.1988.41 Nagel, 1988, Decreased iodine-123 IMP caudate nucleus uptake in patients with Huntington's disease, Clin Nucl Med, 13, 486, 10.1097/00003072-198807000-00002 Reid, 1988, Imaging of cerebral blood flow markers in Huntington's disease using single photon emission computed tomography, J Neurol Neurosurg Psychiatry, 51, 1264, 10.1136/jnnp.51.10.1264 Mazziotta, 1987, Reduced cerebral glucose metabolism in asymptomatic patients at risk for Huntington's disease, N Engl J Med, 316, 357, 10.1056/NEJM198702123160701 Hayden, 1987, Studies in persons at risk for Huntington's disease, N Engl J Med, 317, 382, 10.1056/NEJM198708063170612 Young, 1987, Normal caudate glucose metabolism in persons at risk for Huntington's disease, Arch Neurol, 44, 254, 10.1001/archneur.1987.00520150010010 Leenders, 1986, Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography, Mov Disord, 1, 69, 10.1002/mds.870010110 Hagglund, 1987, Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C-methyl-spiperone, Acta Neurol Scand, 75, 87, 10.1111/j.1600-0404.1987.tb07900.x Rougemont, 1984, Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease, J Neurol Neurosurg Psychiatry, 47, 824, 10.1136/jnnp.47.8.824 Martin, 1984, Cerebral glucose metabolism in Parkinson's disease, Can J Neurol Sci, 11, 169, 10.1017/S0317167100046357 Kuhl, 1984, Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease, Ann Neurol, 15, S119, 10.1002/ana.410150723 Kuhl, 1984, Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method, Ann Neurol, 15, 419, 10.1002/ana.410150504 Leenders, 1986, Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography, J Neurol Neurosurg Psychiatry, 49, 853, 10.1136/jnnp.49.8.853 Garnett, 1984, Central dopaminergic pathways in hemiparkinsonism examined by positron emission tomography, Can J Neurol Sci, 11, 174, 10.1017/S0317167100046369 Tedrroff, 1988, Monoamine re-uptake sites in the human brain evaluated by means of 11C-nomifensine and positron emission tomography: The effects of age and Parkinson's disease, Acta Neurol Scand, 77, 192, 10.1111/j.1600-0404.1988.tb05894.x Hagglund, 1987, Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C-N-methyl-spiperone, Acta Neurol Scand, 75, 87, 10.1111/j.1600-0404.1987.tb07900.x Wijnand, 1987, Tracting of dopamine receptors in hemiparkinsonism with positron emission tomography (PET), J Neurol Sci, 80, 237, 10.1016/0022-510X(87)90158-4 Chiueh, 1986, Determination and visualization of damage to striatal dopaminergic terminals in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism by [18F]-labeled 6-fluoro-L-dopa and positron emission tomography, Adv Neurol, 45, 167 Calne, 1985, Positron emission tomography after MPTP: Observations relating to the cause of Parkinson's disease, Nature, 317, 246, 10.1038/317246a0 Leenders, 1989, Unilateral MPTP lesions in a rhesus monkey: Effects on the striatal dopaminergic system measured in vivo with PET using various novel tracers, Brain Res, 445, 61, 10.1016/0006-8993(88)91074-8 Perlmutter, 1987, MPTP-induced up-regulation of in vivo dopaminergic radio, Neurology, 37, 1575, 10.1212/WNL.37.10.1575 Foster, 1988, Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography, Ann Neurol, 24, 399, 10.1002/ana.410240308 Leenders, 1988, Steel-Richardson-Olszewski syndrome: Brain energy metabolism, blood flow, and fluorodopa uptake measured by positron emission tomography, Brain, 111, 615, 10.1093/brain/111.3.615 Goffinet, 1989, Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy, Ann Neurol, 25, 131, 10.1002/ana.410250205 Andreasen, 1988, Evaluation of brain imaging techniques in mental illness, Ann Rev Med, 39, 335, 10.1146/annurev.me.39.020188.002003 Williamson, 1987, Hypofrontality: A review of the evidence, Can J Psychiatry, 32, 399, 10.1177/070674378703200516 Weinberger, 1988, Speculation on the meaning of cerebral metabolic hypofrontality in schizophrenia, Schizophr Bull, 14, 157, 10.1093/schbul/14.2.157 Wegener, 1989, Positron-emission tomography in neuropsychiatric disorders, Curr Opin Radiology, 1, 475 Cohen, 1989, Quantitative iodine-123 IMP imaging of brain perfusion in schizophrenia, J Nucl Med, 30, 1616 Simon, 1987, Single photon emission computed tomography of the brain with xenon-133 and iodoamphetamine, J Nucl Med, 28, 570 Murrin, 1982, Regional cerebral blood flow patterns in schizophrenic patients, rCBF Bull, 3, 43 Warkentin, 1990, Regional cerebral blood flow in schizophrenia: Repeated studies during a psychotic episode, Psychiatry Res, 35, 27, 10.1016/0925-4927(90)90006-R Mathew, 1988, Abnormal resting regional cerebral blood flow patterns and their correlates in schizophrenia, Arch Gen Psychiatry, 45, 542, 10.1001/archpsyc.1988.01800300038004 Bajc, 1989, Cerebral perfusion inhomogeneities in schizophrenia demonstrated with single photon emission computed tomography and Tc99m-hexamethylpropyleneamineoxim, Acta Psychiatr Scand, 80, 427, 10.1111/j.1600-0447.1989.tb03001.x Devous MD Sr, Raese JD, Herman JH et al: SPECT determination of regional cerebral blood flow in schizophrenic patients at rest and during a mental task. J Nucl Med 27: P734 (abstr) Cohen, 1988, From syndrome to illness: Delineating the pathophysiology of schizophrenia with PET, Schizophr Bull, 14, 169, 10.1093/schbul/14.2.169 Geraud, 1987, Reversibility of hemodynamic hypofrontality in schizophrenia, J Cereb Blood Flow Metab, 7, 9, 10.1038/jcbfm.1987.2 Weinberger, 1986, Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia: Regional cerebral blood flow evidence, Arch Gen Psychiatry, 43, 114, 10.1001/archpsyc.1986.01800020020004 Berman, 1985, Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention and mental effort, Arch Gen Psychiatry, 43, 126, 10.1001/archpsyc.1986.01800020032005 Berman, 1987, Cortical “stress tests” in schizophrenia: Regional cerebral blood flow studies, Biol Psychiatry, 22, 1304, 10.1016/0006-3223(87)90066-7 Gur, 1989, Laterality and frontality of cerebral blood flow and metabolism in schizophrenia: Relationship to symptom specificity, Psychiatry Res, 27, 325, 10.1016/0165-1781(89)90147-9 Gur, 1985, Brain function in psychiatric disorders. III. Regional cerebral blood flow in unmedicated schizophrenics, Arch Gen Psychiatry, 42, 329, 10.1001/archpsyc.1985.01790270015001 Gur, 1987, Regional brain function in schizophrenia I. A positron emission tomography study, Arch Gen Psychiatry, 44, 119, 10.1001/archpsyc.1987.01800140021003 Gur, 1987, Regional brain function in schizophrenia. II. Repeated evaluation with positron emission tomography, Arch Gen Psychiatry, 44, 126, 10.1001/archpsyc.1987.01800140028004 O'Connell, 1987, Single photon emission computed tomography in psychiatry, Clin Nucl Med, 12, P13, 10.1097/00003072-198709001-00014 Notardonato, 1989, The potential value of serial cerebral SPECT scanning in the evaluation of psychiatric illness, Clin Nucl Med, 14, 319, 10.1097/00003072-198905000-00001 Musalek, 1988, Neurophysiological aspects of auditory hallucinations. 99mTc-(HMPAO)-SPECT investigations in patients with auditory hallucinations and normal controls —A preliminary report, Psychopathology, 21, 275, 10.1159/000284570 Early, 1987, Left globus pallidus abnormality in never-medicated patients with schizophrenia, Proc Natl Acad Sci USA, 84, 561, 10.1073/pnas.84.2.561 Buchsbaum, 1987, Positron emission tomography studies of basal ganglia and somatosensory cortex neuroloeptic drug effects: Differences between normal controls and schizophrenic patients, Biol Psychiatry, 22, 479, 10.1016/0006-3223(87)90170-3 Baron, 1989, Striatal dopamine receptor occupancy during and following with-drawal from neuroleptic treatment: Correlative evaluation by positron emission tomography and plasma prolactin levels, Psychopharmacology, 99, 463, 10.1007/BF00589893 Sedvall, 1988, PET scanning—A new tool in clinical psychopharmacology, Psychopharmacol Ser, 5, 27 Farde, 1986, Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET, Science, 231, 258, 10.1126/science.2867601 Farde, 1988, Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs, Arch Gen Psychiatry, 45, 71, 10.1001/archpsyc.1988.01800250087012 Farde, 1987, No D2 receptor increase in PET study of schizophrenia, Arch Gen Psychiatry, 44, 671, 10.1001/archpsyc.1987.01800190091013 Martinot, 1990, Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patients, Am J Psychiatry, 147, 44, 10.1176/ajp.147.1.44 Wong, 1986, Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics, Science, 234, 1558, 10.1126/science.2878495 Kung, 1990, In vivo SPECT imaging of CNS D-2 dopamine receptors: Initial studies with iodine-123-IBZM in humans, J Nucl Med, 31, 573 Guze, 1990, PET offers insights into the physiology of mood disorders, J Clin Brain Imaging, 1, 13 Silfverskiold, 1989, Regional cerebral blood flow in depression and mania, Arch Gen Psychiatry, 46, 253, 10.1001/archpsyc.1989.01810030059008 Schlegel, 1989, Regional cerebral blood flow in depression: Associations with psychopathology, J Affective Disord, 17, 211, 10.1016/0165-0327(89)90002-5 Phelps, 1984, Positron emission tomographic study of affective disorders: Problems and strategies, Ann Neurol, 15, S149, 10.1002/ana.410150729 Schwartz, 1987, The differential diagnosis of depression: Relevance of positron emission tomography studies of cerebral glucose metabolism to the bipolar-unipolar dichotomy, JAMA, 258, 1368, 10.1001/jama.1987.03400100102031 Baxter, 1985, Cerebral metabolic rates for glucose in mood disorders, Arch Gen Psychiatry, 42, 441, 10.1001/archpsyc.1985.01790280019002 Buchsbaum, 1986, Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with 18F-2-deoxyglucose in affective illness, J Affective Disord, 10, 137, 10.1016/0165-0327(86)90036-4 Mayberg, 1988, PET imaging of cortical S2 serotonin receptors after stroke: Lateralized changes and relationship to depression, Am J Psychiatry, 145, 937, 10.1176/ajp.145.8.937 Wik, 1988, Positron emission tomography determination of regional cerebral glucose metabolism in alcohol-dependent men and healthy controls using 11C-glucose, Acta Psychiatr Scand, 78, 234, 10.1111/j.1600-0447.1988.tb06330.x Jolles, 1989, PET, CT, and MRI in the evaluation of neuropsychiatric disorders: Current applications, J Nucl Med, 30, 1589